Defence Therapeutics Inc.
Defence Therapeutics Inc.
Indice CSE:
Devise:
Defence Therapeutics Inc. is a biotechnology company engaged in the business of research and development, focusing on enhancing delivery of tumor-/ and infectious disease-specific therapeutics. The principal business carried on is the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.
Defence Therapeutics Inc. (DTC)
Information d'entreprise
Addresse
1615, 200 Burrard St.
Vancouver, BC V6C 3L6
CanadaTéléphone
604-753-8834Courriel
sebas.plouffe@gmail.comURL
https://defencetherapeutics.comDate d’inscription à la cote
Vendredi, mai 7, 2021
Agent de transfert
Computershare Investor Services Inc.SEDAR Information
Information d'entreprise
Addresse
1615, 200 Burrard St.
Vancouver, BC V6C 3L6
CanadaTéléphone
604-753-8834Courriel
sebas.plouffe@gmail.comURL
https://defencetherapeutics.comDate d’inscription à la cote
Vendredi, mai 7, 2021
Agent de transfert
Computershare Investor Services Inc.Capitalisation
Capitalisation:
54725370Réservé à l'émission:
6437785Company Officers
P. Joseph Meagher, Chief Financial Officer
Sebastien Plouffe, President and Chief Executive Officer
Arnab De, CFO
Communiqués de presse
